Recent findings consolidate the pleiotropic nature of IL-6 and demonstrate a physiological role of this myokine in regulating clinically relevant parameters related to energy homeostasis and immune cell regulation in cancer (Severinsen and Pedersen, 2020). This evidence concerns the gene IL6 and cancer.